To read this content please select one of the options below:

Russia justifies overriding COVID-19 drug patent

Content type:: Executive Summary
Location:: RUSSIA
Keywords associated with this article:: Geographic: Russia RUCIS

Topical: economy industry international relations foreign trade government international law manufacturing pharmaceutical
ISSN:: 2633-304X
Citation:: Oxford Analytica (2021), "Russia justifies overriding COVID-19 drug patent", Expert Briefings.
https://doi.org/10.1108/OXAN-ES261786

Friday, May 28, 2021

RUSSIA: Moscow justifies unlicensed COVID drug permit